In vitro bactericidal activity of ceftobiprole against hospital- and community-associated methicillin resistant Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2010, Pages 591-594

  Borbone, Sonia ^a   Campanile, Floriana ^a   Bongiorno, Dafne ^a   Stefani, Stefania ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

CA MRSA; HA MRSA; hVISA; Killing curves; MRSA; Paradoxical killing; Population analysis

Indexed keywords

CEFTOBIPROLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; RO 639141; TEICOPLANIN; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; BROTH DILUTION; ENZYME INHIBITION; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; STAPHYLOCOCCAL INFECTIONS;

EID: 77950311951     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp483     Document Type: Letter

References (13)

1. Hebeisen P, Heinze-Krauss I, Angehrn P et al. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrobial Agents Chemother 2001; 45: 825-36.
2. Vidaillac C, Rybak MJ. Ceftobiprole: first cephalosporin with activity against methicillin-resistant Staphylococcus aureus. Pharmacotherapy 2009; 29: 511-25.
3. Noel GJ, Strauss RS, Amsler K et al. Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by Gram-positive bacteria. Antimicrob Agents Chemother 2008; 52: 37-44.
4. Campanile F, Bongiorno D, Borbone S et al. Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy. Ann Clin Microbiol Antimicrob 2009; 8: 22.
5. Stefani S, Bongiorno D, Cafiso V et al. Pathotype and susceptibility profile of a community-acquired methicillin-resistant Staphylococcus aureus strain responsible for a case of severe pneumonia. Diagn Microbiol Infect Dis 2009; 63: 100-4.
6. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 8th edn. Approved Standard M7-A8. CLSI, Wayne, PA, USA, 2009.
7. Vaudaux P, Gjinovci A, Bento M et al. Intensive therapy with ceftobiprole medocaril of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2005; 49: 3789-93.
8. Leonard SN, Cheung CM, Rybak MJ. Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2008; 52: 2974-6.
9. Deshpande LM, Jones RN. Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci. Clin Microbiol Infect 2003; 9: 1120-4.
10. EUCAST. Clinical Breakpoints. http://www.srga.org/eucastwt/MICTAB/index.html (3 December 2009, date last accessed).
11. Lodise TP Jr, Pypstra R, Kahn JB et al. Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects. Antimicrob Agents Chemother 2007; 51: 2378-87.
12. Hersh AL, Chambers HF, Maselli JH et al. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168: 1585-91.
13. Gustafson JE, Wilkinson BJ. Lower autolytic activity in a homogeneous methicillin-resistant Staphylococcus aureus strain compared to derived heterogeneous-resistant and susceptible strains. FEMS Microbiol Lett 1989; 50: 107-11.